Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_provenance.
- NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_assertion description "[Cyclolignan picropodophyllin (PPP), a specific inhibitor of IGF-1R kinase activity, strongly down-regulated the basal levels of AKT activity in WM9 and in WM793 cells, modestly does so in LU1205, but has no effect on AKT activity in the early stage WM35 cells that are deficient in IGF-1R.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_provenance.
- NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_assertion evidence source_evidence_literature NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_provenance.
- NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_assertion SIO_000772 20417200 NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_provenance.
- NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_assertion wasDerivedFrom befree-20140225 NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_provenance.
- NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_assertion wasGeneratedBy ECO_0000203 NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP522650.RA_xajtyEMWc8VvQE2PngoK_bbmQfChXOgVr-okdz_ncY130_provenance.